Uremic pruritus treated successfully with the Goeckerman Program.

Area of Science:

• Nephrology
• Dermatology
• Photomedicine

Background:

• Uremic pruritus (UP) is a prevalent and distressing symptom for patients undergoing hemodialysis (HD) due to chronic kidney disease (CKD).
• Current therapeutic strategies for UP, including topical corticosteroids, antihistamines, and phototherapy, often provide inadequate relief for severe cases.
• The pathophysiology of UP remains incompletely understood, contributing to a lack of evidence-based treatment guidelines.

Observation:

• A case of severe UP, resistant to standard treatments, was observed in a CKD patient on HD.
• The Goeckerman regimen, a combination therapy involving topical coal tar, topical corticosteroids, and broadband ultraviolet B (BB-UVB) radiation, was administered.
• Successful management of the severe and recalcitrant pruritus was achieved using this regimen.

Findings:

• The Goeckerman regimen demonstrated significant efficacy in alleviating severe uremic pruritus that was refractory to conventional treatments.
• This case highlights the potential of combining topical agents with BB-UVB phototherapy for managing intractable UP.
• The successful outcome suggests a viable therapeutic option for patients with severe, treatment-resistant itching associated with CKD and HD.

Implications:

• The Goeckerman regimen presents a promising therapeutic avenue for severe uremic pruritus, particularly when standard treatments are ineffective.
• Further clinical studies are warranted to validate these findings and establish the role of the Goeckerman regimen in UP management.
• This approach may offer improved quality of life for CKD patients suffering from debilitating pruritus.